Stocks in news today

has received Letter of Acceptance worth Rs 105.69 crore, excluding GST, from Research Designs and Standards Organisation (RDSO), Lucknow for Comprehensive maintenance contract of dedicated test track between Gudha and Thathana Mithri stations of Jodhpur division of NWR. , through its various step-down subsidiaries, has operationalized an aggregate 510.1 MW power projects at Khavda, Gujarat. With commissioning of these plants, the company’s total operational renewable generation capacity has increased to 17,982.3 MW. SUGS Lloyd has secured a major order worth Rs 639.24 crore (including GST) from Konkan Railway Corporation. The project involves supply, installation, testing and commissioning of plant contract along with SCADA-DMS systems, to be executed over a period of 24 months. !Dr. Reddy's Laboratories has launched its injectable semaglutide under the brand name Obeda, marking an important step in expanding access to advanced GLP 1 receptor agonist-based therapy for the management of type 2 diabetes in India. The company has been the first Indian company to receive Drugs Controller General of India (DCGI) approval for generic semaglutide. This launch underscores the company’s Day 1 entry into the segment upon patent expiry, demonstrating its readiness to serve unmet patient needs in India. India’s wholly owned subsidiary -- Ceigall Infra projects (CIPPL) has emerged as the L1 bidder for project by the National Highways Authority of India (NHAI). The project is for the construction of 6-lane access-controlled Spur connectivity starting from Ch. 15+100 of Ambala - Chandigarh section of NH-205A and terminating at Ch. 2+500 of Zirakpur Bypass (Total length 10.300 Km) under NH(O) in the state of Punjab on Hybrid Annuity Mode. The Bid cost of the project is Rs 603.00 crore.